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Abstract The atypical low density lipoprotein (LDL) binding
proteins (Mr 105 and 130 kDa; p105 and p130) in human aortic
medial membranes and cultured human and rat aortic smooth
muscle cells (SMC) have recently been identified as the cell
adhesion glycoprotein T-cadherin. Although cadherins are
generally recognized to be important regulators of morphogen-
esis, the function of T-cadherin in the vasculature is poorly
understood. This study has examined the relationship between
expression of T-cadherin and the density and proliferation status
of SMC. T-cadherin (p105 and p130) levels in SMC lysates were
measured on Western blots using ligand-binding techniques.
T-cadherin expression was dependent upon cell density, and
maximal levels were achieved at confluency. T-cadherin levels
were reversibly modulated by switching cultures between serum-
free (upmodulation) and serum-containing (downmodulation)
conditions. Platelet-derived growth factor (PDGF)-BB, epider-
mal growth factor (EGF) or insulin-like growth factor (IGF)
elicited a dose- and time-dependent downmodulation that was
reversible after transfer of SMC to growth factor-free medium.
Our results support the hypothesis that T-cadherin may function
as a negative determinant of cell growth.
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1. Introduction
Human medial tissue and cultured human and rat aortic
smooth muscle cells (SMC) contain two atypical lipoprotein-
binding proteins with molecular weights of 105 kDa (p105)
and 130 kDa (p130) [1,2]. Binding of low-density lipoprotein
(LDL) to these proteins is speci¢c and displays properties that
are distinct from those of all other previously described lipo-
protein recognizing proteins [1,2]. Partial amino acid se-
quencing of p105 puri¢ed from human medial tissue revealed
its putative identity as the glycosylphosphoinositol-anchored
cell adhesion glycoprotein T-cadherin [3]. Common identity of
p105 and p130 as T-cadherin in cultured human and rat aortic
SMC was deduced on the basis of their common immuno-
reactivity with anti-T-cadherin peptide antibodies and suscept-
ibility to phosphatidylinositol-speci¢c phospholipase C cleav-
age [4]. Additionally, and in accordance with data in chicken
T-cadherin transfected Chinese hamster ovary (CHO) cells [5],
trypsin treatment of SMC in the presence of calcium results in
a synchronous loss of precursor T-cadherin (p130) and in-
crease of the trypsin/calcium-insensitive mature T-cadherin
(p105) [4]. Each member of the cadherin family has a unique
calcium-dependent homophilic binding speci¢city which link
together cells expressing the same cadherin type [6^9]. These
homophilic interactions de¢ne the adhesion selectivities im-
portant in regulating cell adhesion, morphology and motility
[6^9].
In the nervous system developmental studies in chick have
suggested that T-cadherin expression might be a negative de-
terminant of synaptogenesis in skeletal muscle and that it may
serve as a barrier to motor neuron sprouting [10,11]. A neg-
ative function in growth control is supported by in vitro stud-
ies of neurite growth on T-cadherin substrata whereby T-cad-
herin was found to serve a homotypic avoidance function [11].
Further evidence for a negative role for T-cadherin in cell
growth derives from the observation that T-cadherin mRNA
is either absent or signi¢cantly reduced in human breast car-
cinoma lines and breast cancer specimens [12]. Transfection of
a breast carcinoma with T-cadherin cDNA signi¢cantly inhib-
ited growth, and this inhibition was overcome by inclusion of
anti-T-cadherin antibodies [12]. The role of T-cadherin in the
vasculature is unclear. However, some function associated
with growth control can be deduced from our recent obser-
vations that T-cadherin levels in SMC can be altered by mi-
togenic (decreased) and anti-mitogenic (increased) compounds
[4]. In order to more speci¢cally de¢ne the role for T-cadherin
in growth control of SMC we conducted a detailed investiga-
tion of the density-dependent and proliferation-status depend-
ent expression of T-cadherin protein.
2. Materials and methods
2.1. Preparation of lipoproteins and lipoprotein-de¢cient serum
Lipoproteins (low-density (LDL), high-density (HDL) and very
low-density (VLDL)) were isolated from the plasma of healthy male
humans using sequential buoyant density centrifugation techniques
[13]. LDL (density 1.019^1.063 g/ml) was biotinylated using D-bio-
tin-N-hydroxysuccinimide [14]. Lipoprotein-de¢cient serum (LPDS)
was prepared from fetal calf serum (FCS) [15].
2.2. Smooth muscle cell culture
Procedures for the isolation, phenotypic characterization and prop-
agation of human aortic SMC (isolated using explant or enzymatic
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disaggregation methods) and rat aortic SMC (isolated using enzy-
matic disaggregation) have been detailed previously [4,16]. For the
studies herein, SMC at between passages 4 and 18 were used. SMC
were normally cultured in Dulbecco’s medium containing 5 mM glu-
tamine, 10 mM TES-NaOH, 10 mM HEPES-NaOH (both at pH 7.3),
0.05 mg/ml gentamycin and 10% FCS. Serum-free medium (SF) was
minimal essential medium containing Earle’s salts and all ingredients
as given above with the exception that serum was substituted with
0.1% (w/v) BSA. Cultures were routinely examined by phase contrast
microscopy for visual evaluation of cell densities. Details of the di¡er-
ent experimental protocols are described in the text and ¢gure legends.
Cells were lysed by addition of 1% SDS/1 mM PMSF [4] and protein
concentrations determined using the Lowry method. Lysates were
stored at 320‡C until use. Even under optimal conditions human
aortic SMC grow very slowly in culture and it is di⁄cult to markedly
in£uence their proliferation status by serum/factor supplementation or
deprivation. In contrast, rat aortic SMC are readily manipulatable
between extremes of rapid growth and quiescence and thus lend them-
selves to exploitation for studies on growth control. This study has
thus preferentially utilized rat SMC. Data obtained with human SMC
(in Fig. 5) were qualitatively comparable, but quantitatively less strik-
ing.
2.3. Ligand-binding and immuno-blotting
All procedures for polyacrylamide gel electrophoresis, electrotrans-
fer onto nitrocellulose (Schleicher and Schuºll), ligand-binding and
immuno-blotting, and quantitation using Adobe Photoshop and
NIH Image computer programmes have been detailed previously
[1^4]. Brie£y, SDS-polyacrylamide (8%) gel electrophoresis was per-
formed under non-reducing conditions, and for any given experiment
identical amounts of protein (10^50 Wg) were loaded per slot. TBS
(150 mM NaCl, 50 mM Tris-HCl, pH 7.4). containing 5% (w/v) de-
lipidated milk (Rapilait milk, Zurich, Switzerland) was used in all pre-
blocking, incubation and washing procedures, with the exception of
incubations with horseradish peroxidase (HRP)-conjugates which
used TBS without milk. Use of ligand (LDL)-binding techniques to
analyze T-cadherin in smooth muscle cells has been previously vali-
dated for whole SMC lysates, membrane extracts from aortic medial
tissue and puri¢ed T-cadherin [3,4]. In this study biotinylated-LDL (at
80 Wg/ml) was used as the ligand in combination with streptavidin-
HRP-conjugate and the Amersham ECL detection system. Detection
images selected for presentation are those illustrating the reversible
(Fig. 2) and speci¢c (Fig. 5) modulation of T-cadherin proteins (p105
and p130). For expression of apo B,E receptor, GsK, and myosin
heavy chain, blots were incubated with monoclonal apo B,E receptor
antibodies (Ab-1, Clone 15C8, Calbiochem; recognizing only human
and bovine apo B,E receptor), polyclonal anti-GsK antibodies (K-20,
Santa Cruz Biotechnology) or monoclonal anti-myosin (smooth)
heavy chain antibodies (Sigma Chemical), and then with the appro-
priate anti-mouse or anti-rabbit IgG-HRP conjugate.
3. Results and discussion
3.1. Density-dependent expression of T-cadherin protein
We ¢rst aimed at determining a relationship between cell
density and T-cadherin protein (p105 and p130 forms) expres-
sion. Cultures of SMC were enzymatically disassociated using
0.25% trypsin/1 mM EDTA (which results in loss of cellular
(surface-located) T-cadherin [4,5]), seeded at di¡erent densities
and thereafter cultured for up to ¢ve days in the presence of
10% FCS. For cultures seeded at the lowest density (0.1U106
cells/well), levels of p105 and p130 proteins increased through-
out during the 5 day culture period (Fig. 1). These cultures
only started to achieve con£uence (assessed by phase-contrast
microscopy) after the 5th day in culture, and it is noteworthy
that at this time point p105 and p130 levels were comparable
to the maximal levels achieved in the more densely seeded
cultures. In the more densely seeded cultures (0.5 and
1.0U106 cell/well), levels of p130 and p105 increased only
until such times as the cells achieved con£uency and prolifer-
ation arrest (2 and 1 days, respectively, for cultures seeded at
0.5 and 1.0U106 cell/well). Thereafter levels of p105 and p130
in these cultures decreased. These data indicate that expres-
sion levels of T-cadherin protein in passaged SMC are indeed
dependent upon cell density, but also appear to be strongly
in£uenced by the proliferation status of the cells.
3.2. Proliferation status-dependent modulation of T-cadherin
protein expression
We next examined the association between T-cadherin pro-
tein expression and the proliferation status of SMC. The pro-
liferation status of subcon£uent rat aortic SMC was modu-
lated by changing culture conditions. SMC were seeded at a
low density and maintained for 24 h under normal growth
conditions (i.e. 10% FCS). Cultures were then maintained
for 3 days under either serum-containing (Fig. 2A) or se-
rum-deprived conditions (Fig. 2B), and thereafter switched
to serum-deprived or serum-containing conditions, respec-
tively, for a further 4 days. For SMC cultured for the ¢rst 3
days in the presence of serum increases in p105 and p130 were
observed during the ¢rst 2 days after which time these cultures
attained con£uence (Fig. 2A). Cultures initially maintained
under SF conditions also exhibited an increase in T-cadherin
protein expression during the ¢rst 2 days only (Fig. 2B).
Although these cultures continued to grow (due to autocrine
production of growth factors [17]), albeit only very slowly,
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Fig. 1. Dependence of T-cadherin protein levels on cell density.
After trypsin/EDTA disaggregation, rat aortic SMC were seeded
(day 0) into 6-well dishes at cell densities of W0.1U106 cells/well
(O,R), W0.5U106 cells/well (E,F), and W1U106 cells/well (a,b),
and cultured for 5 days in the presence of 10% FCS; con£uence in
these di¡erent cultures was achieved after 5, 2 and 1 days, respec-
tively. Levels of p130 (panel A, open symbols) and p105 (B, closed
symbols) in whole cell lysates were measured by ligand-binding as
described in Section 2. Two independent experiments were per-
formed and data are given as means þ S.D. of duplicate determina-
tions from each experiment.
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they did not achieve a state of con£uence within the ¢rst 3
days. Thus the cessation of increases in T-cadherin after 2
days under SF conditions (Fig. 2B) either re£ects a maximal
upmodulation of protein expression and/or is due to negative
e¡ects of autocrine growth factors that have accumulated in
the medium. A striking di¡erence between SF- and FCS-
maintained cultures during the ¢rst 3 days is the relative in-
crease in T-cadherin protein expression. This was much great-
er in SF-maintained cultures (W5-fold increase after 48 h,
Fig. 2B) than FCS-maintained SMC (W2-fold increase after
48 h, Fig. 2A). Following a switch from FCS-containing to SF
conditions (Fig. 2A), expression of T-cadherin proteins mark-
edly increased, whereas the switch from SF to FCS-containing
conditions (Fig. 2B) resulted in a downmodulation of protein
expression.
The above data show a striking association between prolif-
eration status of SMC and levels of T-cadherin expression,
with upmodulation in quiescent or very slow growing cultures
and downmodulation in cultures with high proliferation po-
tential. Additional support of association between expression
of T-cadherin and proliferation/density status in SMC might
be derived from our consistent ¢ndings that the magnitude of
alterations in p105 and p130 levels between SF and serum
conditions is much greater in cultures of rat SMC (2.5^5-
fold), which possess a rapid proliferation potential and
achieve high saturation density, than in cultures of human
SMC (1.3^1.5-fold, see Fig. 5), which possess a slow prolifer-
ation potential and achieve a low saturation density. Our
¢ndings with SMC are in accordance with a study [12] dem-
onstrating that T-cadherin mRNA is present in normal epi-
thelial cells but absent in tumor epithelial cells. Moreover, the
same study demonstrated that reexpression of T-cadherin in
mammary epithelial tumor cells by transfection markedly di-
minished their growth rate and that anti-T-cadherin antibod-
ies blocked the growth inhibitory e¡ect induced by T-cadherin
reexpression [12].
3.3. T-cadherin protein levels are not in£uenced by changes in
cellular lipid/sterol metabolism
Expression levels of all members of the LDL receptor
(LDLR) family that function in cellular lipid transport/sterol
metabolism are known to be variously upmodulated and
downmodulated under conditions that in£uence cellular lipid
metabolism ([18^23]; see also Fig. 5 for regulation of apo B,E
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Fig. 2. Regulation of T-cadherin protein expression in SMC under serum-containing or serum-free culture conditions. Rat aortic SMC were
seeded (at W0.3U106 cells/well) and cultured in the presence of 10% FCS for 24 h (day 0). Thereafter SMC were maintained for a further 3
days under either FCS-containing (panel A) or serum-free (panel B) conditions. On day 3, FCS-maintained cultures were changed to SF condi-
tions (panel A), and SF-maintained cultures were switched back to FCS-containing conditions (panel B). Cell lysates were prepared on each
day (0^7) and then electrophoresed in parallel. Data for levels p105 (b) and p130 (a) are given as mean þ S.D. of duplicate determinations
from three separate experiments. Representative ECL detection images are presented.
Fig. 3. Dose-dependent down-regulation of T-cadherin protein expression by growth factors. Rat aortic SMC were cultured to subcon£uence,
rinsed with SF medium and then further cultured in SF medium for 24 h either without (time 0) or with inclusion of the indicated concentra-
tions of PDGF-BB (panel A), EGF (panel B), or IGF-1 (panel C). T-cadherin was measured in whole cell lysates as described in Section 2.
Data for levels of p105 (b) and p130 (a) are given as mean þ S.D. of duplicate determinations from three separate experiments.
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receptor in human SMC). T-cadherin bears no sequence ho-
mology to the LDLR family proteins. Nevertheless, given that
T-cadherin is an LDL-binding protein [3,4] we investigated
whether serum-dependent downmodulation of T-cadherin
might be due to e¡ects on cellular lipid metabolism. Con£uent
SMC were treated for 24 h (under serum-containing and SF
culture conditions) with LDL, HDL, VLDL (at 100 Wg/ml),
cholesterol (30 Wg/ml), LPDS plus compactin (10% plus
3U1035 M), dexamethasone (1038^1035 M), progesterone
(1038^1035 M) or estradiol (1038^1035 M). None of these
conditions exerted conspicuous e¡ects on either p105 or
p130 levels in either rat or human SMC (complete data not
shown; see Fig. 5 for clear distinctions between T-cadherin
and apo B,E receptor). Serum-dependent downmodulation of
T-cadherin thus involves serum-contained factors other than
those which directly in£uence cellular lipid/sterol metabolism.
Together with the cell surface location and outward orienta-
tion of T-cadherin [4,5], the lack of e¡ect of lipid/sterol me-
tabolism on T-cadherin protein levels can be interpreted to
support that T-cadherin possesses some surface-directed func-
tion other than lipid endocytosis and lipid metabolism.
3.4. Reversible modulation of T-cadherin levels by SMC
peptide growth factors
Speci¢c serum-contained peptide growth factors, including
epidermal growth factor (EGF, 1 ng/ml), platelet derived
growth factor (BB homodimer, PDGF-BB, EC50 W5 ng/
ml), and insulin-like growth factor-1 (IGF1, EC50 W10 ng/
ml) elicited a dose-dependent downmodulation of T-cadherin
(Fig. 4). The reversibility of this modulation was investigated
by studying the kinetics of changes in p105 and p130 protein
levels under SF and PDGF-BB (10 ng/ml)-containing culture
conditions. For this, SMC were passaged and maintained nor-
mally (10% FCS) for 24 h (time 0) and then further cultured
under either SF-to-PDGF (Fig. 4A) or PDGF-to-SF (Fig. 4B)
regimens. In both regimens PDGF-BB was added repeatedly
at 12-hourly intervals. Under the ¢rst regimen expression of
p105 and p130 proteins could be detected within 4^8 h of
serum deprivation and achieved maximal levels within 24 h;
downmodulation of p105 and p130 expression in these cul-
tures occurred promptly following addition of PDGF-BB, de-
clining to minimal levels within 24 h and remaining at this
level for at least the next 24 h (Fig. 4A). If PDGF-BB was
added to cultures once only (i.e. at the 48-h time period) levels
of p105 and p130 protein expression once again started to
increase after the 72-h time period (data not shown). Under
the second regimen in which SMC were ¢rst cultured in the
presence of PDGF-BB, p105 and p130 levels remained sup-
pressed until cultures were switched to SF conditions whereby
expression of the proteins increased within 4^8 h, reached
maximum within 24 h and was sustained over the next 24 h
(Fig. 4B). As for the preceding regimen, repeated additions of
PDGF-BB (i.e. at times 0, 12 and 24 h) were necessary to
maintain a restricted expression of p105 and p130 proteins
over a 48-h period (data not shown). The ability of speci¢c
SMC mitogens to downmodulate T-cadherin protein and the
ready reversibility of downmodulation upon reversion to mi-
togen-free conditions provide further support for a close rela-
tionship between expression of T-cadherin and proliferation
status of SMC.
3.5. Proliferation-dependent alterations in T-cadherin protein
expression are speci¢c
To ensure that changes in T-cadherin protein expression
were speci¢c and not artefacts of general changes in intracel-
lular or membrane proteins we also investigated expression of
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Fig. 4. Time-dependent alteration of T-cadherin protein expression
in SMC cultured under serum-free conditions and in the presence of
PDGF-BB. Rat aortic SMC were seeded (W0.5U106 cells/well) and
cultured in the presence of 10% FCS for 24 h. After rinsing with
SF medium (time 0) SMC were maintained either under SF condi-
tions (panel A) or with inclusion of 10 ng/ml PDGF-BB (panel B).
After 48 h, SF-maintained cultures (panel A) were changed to
PDGF-BB-containing conditions (10 ng/ml PDGF-BB added every
12 h), and PDGF-BB maintained cultures (panel B) were changed
to SF conditions. Cell lysates were prepared at the indicated time
intervals. Data for levels of p105 (b) and p130 (a) are given as
mean þ S.D. of quadruplicate determinations from two separate ex-
periments.
Fig. 5. Speci¢city of changes in levels of T-cadherin proteins: com-
parison with GsK, myosin heavy chain and apo B,E-receptor. Hu-
man SMC were cultured to subcon£uence, and serum-deprived for
48 h. Thereafter SMC were cultured for 24 h in the continued ab-
sence of serum (SF) or in the presence of FCS (10%), LPDS (10%),
LPDS plus compactin (10% plus 3U1035 M) or PDGF-BB (10 ng/
ml). Four separate electrophoresis/electrotransfer runs were made,
and blots were individually incubated for detection of either T-cad-
herin proteins (p105 and p130), GsK, myosin heavy chain, or apo
B,E receptor as described in Section 2. Representative ECL detec-
tion images are presented. Data from densitometric analysis is given
in the text.
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myosin heavy chain (control for cytoskeletal proteins) and
GsK (control for membrane proteins) in cell lysates from
SMC grown under conditions in which p105 and p130 pro-
teins are either minimally (plus serum, or PDGF-BB) or max-
imally (serum-free) expressed. In both human SMC (Fig. 5)
and rat SMC (data not shown) levels of both myosin heavy
chain and GsK proteins remained constant under all experi-
mental conditions (Fig. 5). Additionally, since the di¡erences
between minimal and maximal expression levels were consis-
tently much smaller in human SMC (generally W1.3-fold, see
Fig. 5 for example) than in rat SMC (W2.5^5-fold, see Figs.
2^4), responsiveness of human SMC to di¡erent culture con-
ditions was validated by concomitant examination of T-cad-
herin and apo B,E receptor (as positive control). In accord-
ance with its established regulation [18,24], apo B,E receptor
protein expression in human SMC was low under SF condi-
tions, upregulated enormously (W40-fold above SF) by a
combination of LPDS plus compactin and to a lesser extent
(W5^10-fold above SF) by FCS, PDGF-BB and LPDS (see
Fig. 5). In the same human SMC lysates T-cadherin protein
levels varied as expected (i.e. elevated under serum-free con-
ditions, and reduced in the presence of serum or growth fac-
tor). Apart from validating responsiveness of human SMC
and the speci¢city of changes in T-cadherin protein levels,
the data in Fig. 5 underline that apo B,E receptor and
T-cadherin di¡er signi¢cantly with respect to their expression
regulation, and therefore function.
3.6. Conclusion
We have presented data on in vitro regulation of expression
of the lipoprotein-binding cell adhesion glycoprotein T-cad-
herin (p105 and p130) in SMC, which invoke some function(s)
relevant to control of cell-cell contact (density-dependent ex-
pression) and growth (proliferation-status-dependent expres-
sion). The data are consistent with the notion that changes
in the state of cell di¡erentiation, proliferation and density
often have an e¡ect on the expression of adhesion molecules,
and vice versa [6^9]. The mechanisms whereby levels of
T-cadherin decrease or increase in response to a given culture
condition need to be studied. Since T-cadherin levels were
measured in whole cell lysates the reversibility of alterations
in SMC cannot be attributed to regulation of surface expres-
sion via simple internalization and reappearance of the pro-
teins. We can speculate that downmodulation re£ects a real
reduction of p105 and p130 proteins from the cell surface, via
either negative transcriptional control or enzymatic cleavage,
while upmodulation requires positive transcriptional control
and de novo synthesis.
An additional important issue requiring investigation per-
tains to the physiological relevance of LDL binding to T-cad-
herin. We have previously demonstrated that LDL can pro-
mote SMC proliferation [26,27], and thus might speculate that
the ability of LDL to serve as a speci¢c, soluble heterophilic
ligand for T-cadherin interferes with the homophilic T-cadher-
in interactions that are critical to normal tissue development
and structure. Furthermore, information is emerging that in
addition to their morphogenic function, cell adhesion recep-
tors may also have important functions in signal transduction
cascades (e.g. tyrosine kinases and protein kinase C) that im-
pinge on the regulation of growth and di¡erentiation [25]. It is
not known whether T-cadherin function is linked to signalling
pathways. However, LDL is capable of eliciting growth-asso-
ciated intracellular signals in SMC [26^28] and our current
objective is to investigate whether LDL-induced activation
of signal transduction cascades is mediated via T-cadherin.
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